Theriva Biologics Inc (TOVX)
1.28
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
1.29
+0.01
(+0.78%)
After-Hours: 20:00
Theriva Biologics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.001M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.056M |
| September 30, 2023 | -0.129M |
| June 30, 2023 | -0.009M |
| March 31, 2023 | -0.008M |
| December 31, 2022 | -0.091M |
| September 30, 2022 | -0.011M |
| June 30, 2022 | -0.014M |
| March 31, 2022 | -4.28M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.014M |
| December 31, 2020 | -0.005M |
| September 30, 2020 | -0.004M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.007M |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.003M |
| September 30, 2017 | -0.198M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.011M |
| December 31, 2016 | -0.37M |
| September 30, 2016 | -0.154M |
| June 30, 2016 | -0.001M |
| March 31, 2016 | -0.044M |
| December 31, 2015 | -0.044M |
| September 30, 2015 | -0.396M |
| June 30, 2015 | -0.043M |
| March 31, 2015 | -0.018M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | -0.022M |
| June 30, 2014 | -0.017M |
| March 31, 2014 | -0.004M |
| December 31, 2013 | -0.011M |
| September 30, 2013 | -0.012M |
| June 30, 2013 | -0.01M |
| March 31, 2013 | -0.003M |
| December 31, 2012 | -0.003M |
| September 30, 2012 | -0.007M |
| June 30, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.28M
Minimum
Mar 2022
--
Maximum
Dec 2019
-0.2311M
Average
-0.0045M
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -3.845B |
| Pro-Dex Inc | -0.431M |
| BioCardia Inc | -0.002M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.913M |
| Cash from Financing (Quarterly) | 3.716M |
| Free Cash Flow | -18.84M |
| Free Cash Flow Per Share (Quarterly) | -3.449 |
| Free Cash Flow Yield | -1.80K% |